October 21, 2019 ABIVAX Reports Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference
August 19, 2019 Inclusion of the first patient in Abivax's Phase 2b (ABX464-103) clinical trial for the treatment of hemorrhagic rectocolitis
October 23, 2024 CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners